Law Offices of Howard G. Smith continues its investigation on behalf of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) investors concerning the Company and its officers’ possible violations of federal securities laws.
On May 7, 2020, Elanco announced its financial and operating results for the first quarter of 2020, reporting revenue of $657.7 million and earnings per share of -$0.12, below investors' expectations. Elanco’s President and Chief Executive Officer attributed the disappointing results to "distributor performance," among other things, and stated that Elanco planned "to tighten [its] approach across many facets of [its] distributor relationships."
On this news, the Company’s share price fell $3.05 per share, or over 13%, to close at $19.88 per share on May 7, 2020, thereby injuring investors.
If you purchased Elanco securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.